A Multi-Centre Prospective Community-Based Observational Study on Prediction of Malignant Progression of Clinically Suspicious Oral Lesions with STRATICYTE
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
The purpose of this observational study is to evaluate the utility of the S100A7 immunohistochemistry signature-based assessment - STRATICYTE - in determining the risk of progression to cancer of clinically suspicious oral lesions.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 15
Maximum Age: 90
Healthy Volunteers: f
View:
• Any clinically suspicious lesion biopsied to rule-out oral epithelial dysplasia/oral squamous cell carcinoma
Locations
Other Locations
Canada
Kingsway Oral & Maxillofacial Surgery
RECRUITING
Edmonton
University of Alberta
RECRUITING
Edmonton
Western University
RECRUITING
London
Contact Information
Primary
Jason Hwang, PhD
jhwang@proteocyte.com
(647) 255-1370
Backup
Mark Darling, MSc, MChD
mark.darling@schulich.uwo.ca
(519) 661-2111
Time Frame
Start Date: 2015-03-12
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 500
Treatments
Oral Mucosal Biopsies With or Without Evidence of Epithelial Dysplasia
No evidence of dysplasia~Mild dysplasia~Moderate dysplasia~Severe dysplasia
Authors
Tim McGaw, Mark Darling
Related Therapeutic Areas
Sponsors
Leads: Proteocyte Diagnostics Inc.